MFSD5: A Potential Drug Target Or Biomarker (G84975)

Target Name: MFSD5

NCBI ID: G84975

MFSD5

MFSD5: A Potential Drug Target Or Biomarker

MFSD5 (Molybdate Transporter 2 Homolog) is a gene that encodes a protein known as the molybdate transporter 2 homolog. The molybdate transporter 2 homolog is a protein that is expressed in various tissues and cells throughout the body, including the brain, heart, liver, and kidneys. It is a member of the family of transmembrane proteins known as the anion transporters, which are involved in the transport of a variety of different anions, including molybdate.

MFSD5 is of particular interest as a potential drug target or biomarker because of its involvement in the transport of molybdate, which is a critical antioxidant that is involved in a variety of cellular processes. Molybdate is also an essential component of many different cellular signaling pathways, including the production of reactive oxygen species (ROS) that can damage cellular tissue and contribute to a variety of diseases, such as cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its potential role in drug delivery and biomarker detection, MFSD5 is also of interest as a potential therapeutic target for a variety of different diseases. For example, MFSD5 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, MFSD5 has been shown to be involved in the development and progression of cancer, and may be a useful target for cancer therapies.

MFSD5 is also of interest as a potential biomarker for a variety of different diseases. For example, MFSD5 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and may be a useful biomarker for this disease. Additionally, MFSD5 has been shown to be expressed in the blood vessels of individuals with Parkinson's disease, and may be a useful biomarker for this disease.

In conclusion, MFSD5 is a gene that encodes a protein involved in the transport of molybdate across the membrane of various cells and tissues. It is of particular interest as a potential drug target or biomarker due to its involvement in the transport of molybdate, which is critical for a variety of cellular processes, and its potential involvement in the development and progression of neurodegenerative diseases, cancer, and other diseases. Further research is needed to fully understand the role of MFSD5 in these processes and its potential as a therapeutic target or biomarker.

Protein Name: Major Facilitator Superfamily Domain Containing 5

Functions: Mediates high-affinity intracellular uptake of the rare oligo-element molybdenum

The "MFSD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MFSD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets